SLB, TotalEnergies digital subsurface collaboration adds Chevron as co-developer
Bitget2026/10/06 12:49SLB NV added Chevron to Arena, a digital subsurface collaboration launched with TotalEnergies in 2024. Chevron will invest capital, provide intellectual property, contribute technical expertise to co-develop reservoir engineering, geoscience technologies. Operator experts will be embedded in SLB technology centers to speed product development cycles, target scalable open digital subsurface tools. Collaboration builds on prior joint work that delivered the Intersect reservoir simulator. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Schlumberger Ltd. published the original content used to generate this news brief on October 06, 2026, and is solely responsible for the information contained therein.
- SLB NV added Chevron to Arena, a digital subsurface collaboration launched with TotalEnergies in 2024.
- Chevron will invest capital, provide intellectual property, contribute technical expertise to co-develop reservoir engineering, geoscience technologies.
- Operator experts will be embedded in SLB technology centers to speed product development cycles, target scalable open digital subsurface tools.
- Collaboration builds on prior joint work that delivered the Intersect reservoir simulator.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Morgan Stanley raises CME Group price target to $337
Chip design software leader Synopsys seeks collaboration with Chinese large model laboratories

Former BioNTech executive leads Bambusa Therapeutics (BBTX.US) in sprint to Nasdaq, "boosting" eczema drug trials
Bambusa Therapeutics Inc. has filed for an initial public offering, planning to raise funds for clinical trials of treatments for eczema and other inflammatory diseases.